Armis Centrix™ for VIPR is a commercial vulnerability assessment tool by Armis. Atera Network Discovery is a commercial vulnerability assessment tool by Atera. Compare features, ratings, integrations, and community reviews side by side to find the best vulnerability assessment fit for your security stack.
Based on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:
Healthcare mid-market and enterprise teams that need vulnerability management tied directly to patient safety,not just IT risk,should run Armis Centrix for VIPR. Its Clinical Impact Score reorders remediation by actual clinical consequence rather than CVSS score alone, a distinction that matters when you have 10,000 medical devices and three remediation slots. The platform covers NIST ID.AM and ID.RA solidly, with real-time device inventory and threat intelligence, though it leans toward asset visibility over response automation; this is a prioritization engine first, not a ticketing replacement. Wrong tool if your infrastructure team wants device management divorced from clinical context or needs deep integration with your existing vulnerability scanner output.
SMB and mid-market IT teams already running Atera's RMM will find genuine value in Network Discovery because it eliminates the separate tool tax for basic asset inventory and CVE scanning. The NMAP-powered scanning integrates directly into your existing RMM workflows, cutting the overhead of maintaining a standalone vulnerability scanner. Where it falls short is in forensic depth; this is asset discovery and port-based CVE detection, not a replacement for active vulnerability assessment tools like Nessus or Qualys that fingerprint software versions and test exploitability. Worth deploying if you need continuous visibility into what's connecting to your network. Not worth it if you're already committed to a dedicated CVSS-scoring vulnerability platform.
Healthcare-focused vuln mgmt platform for medical device security & risk prioritization
RMM-integrated network scanner for device discovery, inventory, and CVE detection.
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing Armis Centrix™ for VIPR vs Atera Network Discovery for your vulnerability assessment needs.
Armis Centrix™ for VIPR: Healthcare-focused vuln mgmt platform for medical device security & risk prioritization. built by Armis. headquartered in United States. Core capabilities include Real-time medical device inventory and visibility, Vulnerability detection and deduplication, Clinical Impact Score for patient safety prioritization..
Atera Network Discovery: RMM-integrated network scanner for device discovery, inventory, and CVE detection. built by Atera. headquartered in Israel. Core capabilities include NMAP-powered network device discovery and cataloging, CVE identification via open port scanning, Real-time alerts for newly connected or unauthorized devices..
Both serve the Vulnerability Assessment market but differ in approach, feature depth, and target audience.
Get strategic cybersecurity insights in your inbox